Zobrazeno 1 - 10
of 19
pro vyhledávání: '"H. M. Reeser"'
Autor:
Jacobus Burggraaf, Rám N. Sukhai, Boudewijn Bakker, Adam F. Cohen, H M Reeser, P Hu, Erica S. Klaassen, Richard H. Klein, B E P B Ballieux, Wilma Oostdijk, Ricardo Alvarez-Jimenez, J.M. Wit, Jan Freijer
Publikováno v:
Hormone Research in Paediatrics, 79(5), 300-309
Klein, R H, Alvarez-Jimenez, R, Sukhai, R N, Oostdijk, W, Bakker, B, Reeser, H M, Ballieux, B E P B, Hu, P, Klaassen, E S, Freijer, J, Burggraaf, J, Cohen, A F & Wit, J M 2013, ' Pharmacokinetics and pharmacodynamics of orally administered clonidine : A model-based approach ', Hormone Research in Paediatrics, vol. 79, no. 5, pp. 300-309 . https://doi.org/10.1159/000350819
Hormone Research in Paediatrics, 79(5), 300-309. S. Karger AG
Klein, R H, Alvarez-Jimenez, R, Sukhai, R N, Oostdijk, W, Bakker, B, Reeser, H M, Ballieux, B E P B, Hu, P, Klaassen, E S, Freijer, J, Burggraaf, J, Cohen, A F & Wit, J M 2013, ' Pharmacokinetics and pharmacodynamics of orally administered clonidine : A model-based approach ', Hormone Research in Paediatrics, vol. 79, no. 5, pp. 300-309 . https://doi.org/10.1159/000350819
Hormone Research in Paediatrics, 79(5), 300-309. S. Karger AG
Background/Aims: The oral clonidine test is a diagnostic procedure performed in children with suspected growth hormone (GH) deficiency. It is associated with untoward effects, including bradycardia, hypotension and sedation. Serum clonidine levels ha
Autor:
H. M. Reeser
Publikováno v:
Bijblijven. 22:286-291
Diabetes mellitus is een ingrijpende chronische ziekte op de kinderleeftijd. De aandoening heeft voor de adolescent verstrekkende implicaties op zowel korte als lange termijn. Dit artikel behandelt die verschillende aspecten en implicaties.
Autor:
Nicolette J. T. Arends, Jaap Mulder, C Rongen-Westerlaken, V.H. Boonstra, J.J.J. Waelkens, R. J. Odink, H. A. Delemarre-van de Waal, M. Jansen, Wilhelmina H. Stokvis-Brantsma, Paul G.H. Mulder, A.C.S. Hokken-Koelega, H. M. Reeser
Publikováno v:
Clinical Endocrinology. 59:779-787
BACKGROUND To investigate in a group of short children born small for gestational age (SGA), the effects of 3 years of GH treatment vs. no treatment on bone age (BA), height and bone mineral density (BMD). Also, to evaluate the influence of the sever
Autor:
Stenvert L. S. Drop, T. Stijnen, Barto J. Otten, M. Jansen, H. M. Reeser, Guy Massa, T. Vulsma, C.W. Rouwé, S.M.P.F. de Muinck Keizer-Schrama, J. J. G. Hoorweg-Nijman, C Rongen-Westerlaken, Willem J M Gerver, J. J. Gosen, Theo C. J. Sas
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:4607-4612
Short stature and ovarian failure are the main features in Turner syndrome (TS). To optimize GH and estrogen treatment, we studied 68 previously untreated girls with TS, age 2–11 yr, who were randomly assigned to one of three GH dosage groups: grou
Autor:
T. Stijnen, H. A. Delemarre-van de Waal, Willem J M Gerver, A. van Teunenbroek, S.M.P.F. de Muinck Keizer-Schrama, J.J.J. Waelkens, J.M. Wit, H. M. Reeser, Stenvert L. S. Drop, T. Vulsma, M. Jansen
Publikováno v:
Clinical Endocrinology, 451-459. Wiley-Blackwell Publishing Ltd
ISSUE=46;STARTPAGE=451;ENDPAGE=459;ISSN=0300-0664;TITLE=Clinical Endocrinology
ISSUE=46;STARTPAGE=451;ENDPAGE=459;ISSN=0300-0664;TITLE=Clinical Endocrinology
GH is known to improve height velocity in girls with Turner syndrome (TS) but the optimal dosage regimen has yet to be defined. OBJECTIVE We attempted to improve the growth response by trying to mimic normal pulsatile GH secretion more closely. DESIG
Autor:
C.W. Rouwé, C Rongen-Westerlaken, Jan M. Wit, A. van Teunenbroek, T. Stijnen, J. J. Gosen, Stenvert L. S. Drop, H A Delemarre-van de Waal, M. Jansen, T. Vulsma, B.J. Otten, S.M.P.F. de Muinck Keizer-Schrama, H. M. Reeser
Publikováno v:
Journal of clinical endocrinology and metabolism, 81(11), 4013-4021. The Endocrine Society
To optimize the growth promoting effect of growth hormone (GH), 65 previously untreated girls with Turner syndrome (TS), chronological age (CA) 2-11 yr, were randomized into 3 dosage regimen groups: A, B, and C, with a daily recombinant-human GH dose
Autor:
Johnny, Ludvigsson, David, Krisky, Rosaura, Casas, Tadej, Battelino, Luis, Castaño, James, Greening, Olga, Kordonouri, Timo, Otonkoski, Paolo, Pozzilli, Jean-Jacques, Robert, Henk J, Veeze, Jerry, Palmer, Ulf, Samuelsson, Helena, Elding Larsson, Jan, Åman, Gunilla, Kärdell, Jan, Neiderud Helsingborg, Göran, Lundström, Eva, Albinsson, Annelie, Carlsson, Maria, Nordvall, Hans, Fors, Carl-Göran, Arvidsson, Stig, Edvardson, Ragnar, Hanås, Karin, Larsson, Björn, Rathsman, Henrik, Forsgren, Helena, Desaix, Gun, Forsander, Nils-Östen, Nilsson, Carl-Göran, Åkesson, Päivi, Keskinen, Riitta, Veijola, Timo, Talvitie, Klemens, Raile, Thomas, Kapellen, Walter, Burger, Andreas, Neu, Ilse, Engelsberger, Bettina, Heidtmann, Suzanne, Bechtold, David, Leslie, Francesco, Chiarelli, Alesandro, Cicognani, Giuseppe, Chiumello, Franco, Cerutti, Gian Vincenzo, Zuccotti, Ana, Gomez Gila, Itxaso, Rica, Raquel, Barrio, Maria, Clemente, Maria José, López Garcia, Mercedes, Rodriguez, Isabel, Gonzalez, Juan Pedro, Lopez, Mirentxu, Oyarzabal, H M, Reeser, Roos, Nuboer, Pauline, Stouthart, Natasa, Bratina, Nina, Bratanic, Marc, de Kerdanet, Jacques, Weill, Nicole, Ser, Pascal, Barat, Anne Marie, Bertrand, Jean-Claude, Carel, Rachel, Reynaud, Regis, Coutant, Sabine, Baron
Publikováno v:
The New England journal of medicine. 366(5)
The 65-kD isoform of glutamic acid decarboxylase (GAD65) is a major autoantigen in type 1 diabetes. We hypothesized that alum-formulated GAD65 (GAD-alum) can preserve beta-cell function in patients with recent-onset type 1 diabetes.We studied 334 pat
Autor:
W. M. C. van Aalderen, A C. E. de Blécourt, M. A. Benninga, R. Didden, M. Elich, J. T. H. N. de Faber, E. A. B. de Graaf, D. Gringhuis, I. J. M. de Groot, J. A. Heineman-de Boer, J. J. E. Hendriks, P. J. Hendriks-Hofman, A. Jennekens-Schinkel, R. P. Kamphuis, H. Knoors, B. F. Last, J. M. G. Moonen, J. M. H. de Moor, H. M. Reeser, J. J. Schweizer, E. J. Siderius, G. Sinnema, A. B. Sprikkelman, H. F. N. Swanenburg de Veye, E. A. K. Wauters, J. W. Weber, P. A. van Woudenberg
Publikováno v:
Ziekten en handicaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b00e6335e9b34d7e94a19535908fcaa
https://doi.org/10.1007/978-90-313-7834-0
https://doi.org/10.1007/978-90-313-7834-0
Autor:
H. M. Reeser
Publikováno v:
Ziekten en handicaps ISBN: 9789031378333
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa883f56ba6a94d72423c2b289e5dbe8
https://doi.org/10.1007/978-90-313-7834-0_6
https://doi.org/10.1007/978-90-313-7834-0_6
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 148(37)
To determine the incidence and characteristics of type-1 diabetes mellitus (DM) in children aged 0-14 years during the period 1996-1999 and to compare this with previous measurements of the incidence.Descriptive.Data were collected via reports from a